These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 28539767)

  • 1. Serum erythropoietin levels in patients with central serous chorioretinopathy.
    Turgut B; Ilhan N; Uyar FY; Celiker U; Demir T; Koca SS
    Eye Brain; 2010; 2():77-81. PubMed ID: 28539767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between the central serous chorioretinopathy, choroidal thickness, and serum hormone levels.
    Çiloğlu E; Unal F; Dogan NC
    Graefes Arch Clin Exp Ophthalmol; 2018 Jun; 256(6):1111-1116. PubMed ID: 29671064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QT interval dispersion in the patients with central serous chorioretinopathy.
    Dagli N; Turgut B; Tanyildizi R; Kobat S; Kobat MA; Dogdu O
    Int J Ophthalmol; 2015; 8(1):61-5. PubMed ID: 25709909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of serum endothelin-1 level in the etiopathogenesis of central serous chorioretinopathy.
    Türkçüoğlu P; Kadayifçilar S; Eldem B
    Am J Ophthalmol; 2006 Aug; 142(2):349-51. PubMed ID: 16876532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial DNA as a Biomarker for Acute Central Serous Chorioretinopathy: A Case-Control Study.
    Hashida N; Asao K; Hara C; Quantock AJ; Saita R; Kurakami H; Maruyama K; Nishida K
    Front Med (Lausanne); 2022; 9():938600. PubMed ID: 35801206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can Hypothyroidism Cause Acute Central Serous Chorioretinopathy?
    Ulaş F; Uyar E; Tekçe H; Çelebi S
    Semin Ophthalmol; 2019; 34(7-8):533-540. PubMed ID: 31646925
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation and correlation of stress scores with blood pressure, endogenous cortisol levels, and homocysteine levels in patients with central serous chorioretinopathy and comparison with age-matched controls.
    Agarwal A; Garg M; Dixit N; Godara R
    Indian J Ophthalmol; 2016 Nov; 64(11):803-805. PubMed ID: 27958201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of 4G/5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in central serous chorioretinopathy and its association with plasma PAI-1 levels.
    Sogutlu Sari E; Yazici A; Eser B; Erol MK; Kilic A; Ermis SS; Koytak A; Akşit H; Yakut T
    Cutan Ocul Toxicol; 2014 Dec; 33(4):270-4. PubMed ID: 24446892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Central Serous Chorioretinopathy with Psychosocial Factors is Dependent on Its Phase and Subtype.
    Kim YK; Woo SJ; Park KH; Chi YK; Han JW; Kim KW
    Korean J Ophthalmol; 2018 Aug; 32(4):281-289. PubMed ID: 30091306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum erythropoietin levels in thalassemia major and intermedia.
    Chaisiripoomkere W; Jootar S; Chanjarunee S; Ungkanont A
    Southeast Asian J Trop Med Public Health; 1999 Dec; 30(4):786-8. PubMed ID: 10928378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choroidal hemodynamic changes during isometric exercise in patients with inactive central serous chorioretinopathy.
    Tittl M; Maar N; Polska E; Weigert G; Stur M; Schmetterer L
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4717-21. PubMed ID: 16303970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretinal antibodies in central serous chorioretinopathy: prevalence and clinical implications.
    Ten Berge JCEM; van Dijk EHC; Schreurs MWJ; Vermeer J; Boon CJF; Rothova A
    Acta Ophthalmol; 2018 Feb; 96(1):56-62. PubMed ID: 28444929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: Predisposing Factors for Visual Acuity Outcomes.
    Matušková V; Vysloužilová D; Uher M
    Semin Ophthalmol; 2018; 33(5):690-699. PubMed ID: 29252091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral Vascular Endothelial Dysfunction in Central Serous Chorioretinopathy.
    Wang NK; Fu Y; Wang JP; Kang EY; Wu AL; Tseng YJ; Yeh LK; Chen KJ; Wu WC; Ho WJ; Lai CC
    Invest Ophthalmol Vis Sci; 2017 Sep; 58(11):4524-4529. PubMed ID: 28877318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axial length in unilateral idiopathic central serous chorioretinopathy.
    Moon H; Lee DY; Nam DH
    Int J Ophthalmol; 2016; 9(5):717-20. PubMed ID: 27275428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of anti-VEGF medications for central serous chorioretinopathy: a meta-analysis.
    Ji S; Wei Y; Chen J; Tang S
    Int J Clin Pharm; 2017 Jun; 39(3):514-521. PubMed ID: 28386700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA).
    Sulzbacher F; Schütze C; Burgmüller M; Vécsei-Marlovits PV; Weingessel B
    Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1581-1590. PubMed ID: 31037488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of tumor necrosis factor-alpha and interferon-gamma on erythropoietin production and erythropoiesis in cancer patients with anemia].
    Wang W; Zhang MH; Yu Y; Xu CG
    Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):681-4. PubMed ID: 18399174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine levels of the aqueous humour in central serous chorioretinopathy.
    Jung SH; Kim KA; Sohn SW; Yang SJ
    Clin Exp Optom; 2014 May; 97(3):264-9. PubMed ID: 24417755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of Central Serous Chorioretinopathy in Male Androgen Abusers.
    Subhi Y; Windfeld-Mathiasen J; Horwitz A; Horwitz H
    Ophthalmol Ther; 2023 Apr; 12(2):1073-1080. PubMed ID: 36692812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.